Sign in
4

Changes in Ownership

Foghorn Therapeutics Inc. Filed Acc 0001193125-26-014218

Options or other derivatives

  • Director acquired 4,470,936 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Flagship Pioneering, LLC Director 2026-01-13 Grant or award · Pre-Funded Warrants to purchase Common Stock +2,235,468 $6.71 $14,999,767 2,235,468 I
Flagship Pioneering, LLC Director 2026-01-13 Grant or award · Series 1 Warrants to purchase Common Stock +1,117,734 1,117,734 I
Flagship Pioneering, LLC Director 2026-01-13 Grant or award · Series 2 Warrants to purchase Common Stock +1,117,734 1,117,734 I
Loading xslF345X05/ownership.xml…